About SPRAVATO® For depressive symptoms in adults with
MDD with suicidal thoughts or actions

Get to Know SPRAVATO®

Nasal spray you self-administer under the supervision of a healthcare provider.

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).^†

Only available at a certified SPRAVATO® treatment center.

Taken with an oral antidepressant.

Patients who stayed on SPRAVATO® continued to improve through Day 25 of treatment during the clinical studies.*

Tell your healthcare provider if you have a history of drug or alcohol abuse.

After you take SPRAVATO®, a healthcare provider will monitor you for at least two hours during the observation period for possible serious side effects, including feeling sleepy (sedation), feeling disconnected from yourself, your thoughts, feelings and things around you (dissociation), and increased blood pressure. More About Side Effects

Nasal spray you self-administer under the supervision of a healthcare provider.

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).^†

Only available at a certified SPRAVATO® treatment center.

After you take SPRAVATO®, a healthcare provider will monitor you for at least two hours during the observation period for possible serious side effects, including feeling sleepy (sedation), and feeling disconnected from yourself, your thoughts, feelings and things around you (dissociation), and increased blood pressure. More About Side Effects

Taken with an oral antidepressant.

Patients who stayed on SPRAVATO® continued to improve through Day 25 of treatment during the clinical studies.*

Tell your healthcare provider if you have a history of drug or alcohol abuse.

*In clinical trials of adults who took SPRAVATO® and an oral antidepressant compared to those who received a placebo and an oral antidepressant. Based on an overall score on a standardized rating scale.

^†All patients received comprehensive standard of care treatment, including an initial inpatient hospitalization and a newly initiated or optimized oral antidepressant therapy, which was determined by a healthcare provider.

SPRAVATO® Dosing for MDD with Suicidal Thoughts or Actions

After you and your healthcare provider have decided SPRAVATO® is right for you – and you understand the benefits and risks of SPRAVATO® – you’ll be ready to start planning for treatment.

You’ll administer SPRAVATO® nasal spray yourself under the supervision of a healthcare provider in a certified SPRAVATO® treatment center
SPRAVATO® is taken twice a week for four weeks, along with an oral antidepressant
After four weeks, you and your healthcare provider will determine if continued treatment with SPRAVATO® is necessary

SPRAVATO® Safety & Tolerability

Do not take SPRAVATO® if you have a blood vessel disease (aneurysm), an abnormal connection between your blood vessels (arteriovenous malformation), a history of bleeding in the brain or if you are allergic to esketamine, ketamine or any of the ingredients in SPRAVATO®. Talk to your healthcare provider to learn more.

SPRAVATO® Side Effects

Serious side effects include feeling sleepy (sedation), dissociation, abuse, increased risk of suicidal thoughts and behavior, increased blood pressure, problems with thinking clearly and bladder problems. The most commonly observed side effects in adults taking SPRAVATO® and an oral antidepressant were:

Dissociation

Feeling disconnected from yourself, your thoughts, feelings and things around you

X
Dizziness
Nausea
Feeling sleepy (sedation)
Spinning sensation
Decreased feeling of sensitivity (numbness)
Feeling anxious
Lack of energy
Increased blood pressure
Vomiting
Feeling drunk
Feeling very happy or excited

After Treatment

A healthcare provider will monitor you for at least two hours. Because of possible side effects affecting mental alertness and motor coordination, you won’t be able to drive, operate machinery or do anything where you need to be completely alert until the next day, following a restful sleep. So you’ll need to plan for rides on treatment days.

What to Expect

How Is SPRAVATO® Different?

How oral antidepressants work

Today’s most commonly used oral antidepressants are thought to treat depression by increasing levels of neurotransmitters (serotonin, norepinephrine and dopamine) in areas of the brain that affect mood.

How SPRAVATO® may work differently

SPRAVATO® targets the N-methyl-D-aspartate (NMDA) receptor and is believed to work differently than currently available oral antidepressants. The exact way that SPRAVATO® works is unknown.

Suicide Prevention Lifeline

If you’re having suicidal thoughts, help is available now. Speak to a counselor at the National Suicide Prevention Lifeline. The Lifeline provides free and confidential 24/7 support for people in distress, as well as prevention and crisis resources.

English
National Suicide Prevention Lifeline

Español
Red Nacional de Prevención del Suicidio

English
1-800-273-8255

Español
1-888-628-9454

The National Suicide Prevention Lifeline is a federally funded network of crisis centers committed to suicide prevention.

Preparing for Treatment

The SPRAVATO® treatment plan.
A different treatment experience.

Learn About Treatment

What is the most important information I should know about SPRAVATO^®?

SPRAVATO^® can cause serious side effects, including:

Sedation and dissociation. SPRAVATO^® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation).
- Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out.
- Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO^®. Your healthcare provider will decide when you are ready to leave the healthcare setting.
Abuse and misuse. There is a risk for abuse and physical and psychological dependence with SPRAVATO^® treatment. Your healthcare provider should check you for signs of abuse and dependence before and during treatment with SPRAVATO^®.
- Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.
- Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
SPRAVATO^® Risk Evaluation and Mitigation Strategy (REMS). Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO^® is only available through a restricted program called the SPRAVATO^® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO^® can only be administered at healthcare settings certified in the SPRAVATO^® REMS Program. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program.
Increased risk of suicidal thoughts and actions. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed.
SPRAVATO^® is not for use in children
- Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a higher risk of having suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions.
How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
- Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions.
- Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings.
- Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
Tell your healthcare provider right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
- suicide attempts
- thoughts about suicide or dying
- worsening depression
- other unusual changes in behavior or mood

Do not take SPRAVATO^® if you:

have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs)
have an abnormal connection between your veins and arteries (arteriovenous malformation)
have a history of bleeding in the brain
are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO^®.

If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO^®.

Before you take SPRAVATO^®, tell your healthcare provider about all of your medical conditions, including if you:

have heart or brain problems, including:
- high blood pressure (hypertension)
- slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting
- history of heart attack
- history of stroke
- heart valve disease or heart failure
- history of brain injury or any condition where there is increased pressure in the brain
have liver problems
have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true).
are pregnant or plan to become pregnant. SPRAVATO^® may harm your baby. You should not take SPRAVATO^® if you are pregnant.
- Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO^®.
- If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO^®.
- There is a pregnancy registry for women who are exposed to SPRAVATO^® during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO^® and their baby. If you become pregnant during treatment with SPRAVATO^®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
are breastfeeding or plan to breastfeed. You should not breastfeed during treatment with SPRAVATO^®.

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO^® with certain medicine may cause side effects.

Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.

How will I take SPRAVATO^®?

You will take SPRAVATO^® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Your healthcare provider will show you how to use the SPRAVATO^® nasal spray device.
Your healthcare provider will tell you how much SPRAVATO^® you will take and when you will take it.
Follow your SPRAVATO^® treatment schedule exactly as your healthcare provider tells you to.
During and after each use of the SPRAVATO^® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting.
You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO^®.
If you miss a SPRAVATO^® treatment, your healthcare provider may change your dose and treatment schedule.
Some people taking SPRAVATO^® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO^® and not drink liquids at least 30 minutes before taking SPRAVATO^®.
If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO^®.

What should I avoid while taking SPRAVATO^®?

Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO^®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO^®?”

What are the possible side effects of SPRAVATO^®?

SPRAVATO^® may cause serious side effects including:

See “What is the most important information I should know about SPRAVATO^®?”
Increased blood pressure. SPRAVATO^® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO^® and for at least 2 hours after you take SPRAVATO^®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO^®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.

The most common side effects of SPRAVATO^® when used along with an antidepressant taken by mouth include:

feeling disconnected from yourself, your thoughts, feelings and things around you
dizziness
nausea
feeling sleepy
spinning sensation
decreased feeling of sensitivity (numbness)
feeling anxious
lack of energy
increased blood pressure
vomiting
feeling drunk
feeling very happy or excited

If these common side effects occur, they usually happen right after taking SPRAVATO^® and go away the same day.

These are not all the possible side effects of SPRAVATO^®.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO^® and discuss any questions you may have with your healthcare provider.

cp-170363v1

About SPRAVATO® For depressive symptoms in adults withMDD with suicidal thoughts or actions

Get to Know SPRAVATO®

Nasal spray you self-administer under the supervision of a healthcare provider.

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).†

Only available at a certified SPRAVATO® treatment center.

Taken with an oral antidepressant.

Patients who stayed on SPRAVATO® continued to improve through Day 25 of treatment during the clinical studies.*

Tell your healthcare provider if you have a history of drug or alcohol abuse.

Nasal spray you self-administer under the supervision of a healthcare provider.

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).†

Only available at a certified SPRAVATO® treatment center.

Taken with an oral antidepressant.

Patients who stayed on SPRAVATO® continued to improve through Day 25 of treatment during the clinical studies.*

Tell your healthcare provider if you have a history of drug or alcohol abuse.

SPRAVATO® Dosing for MDD with Suicidal Thoughts or Actions

SPRAVATO® Safety & Tolerability

SPRAVATO® Side Effects

After Treatment

Your Story Matters, Share It

How Is SPRAVATO® Different?

How oral antidepressants work

How SPRAVATO® may work differently

Suicide Prevention Lifeline

Preparing for Treatment

About SPRAVATO® For depressive symptoms in adults with
MDD with suicidal thoughts or actions

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).^†

Greater reduction of depressive symptoms at 24 hours* (compared to those who received a placebo and oral antidepressant).^†